Blood-aware applications open up the world of preventative medicine in ways we never thought possible. With the ability to detect levels that are anything less than optimal, blood-aware technology can draw attention to red-flag biomarkers before they indicate serious illness or produce symptoms, cutting off illness and disease before it strikes.
When prevention isn’t an option, blood-aware technology makes it easy to monitor the progression or regression of an illness, as well as inform treatment options and provide real-time feedback about treatment efficacy.
Our bodies are often primed for illness long before its onset, and a wide range of biomarkers indicate the impending threat. Blood-aware technology makes it possible to identify risk factors - like high cholesterol before the onset of heart disease or raised blood glucose before diabetes - and course-correct before disease takes root. Detectable substances include LDL cholesterol, blood glucose, carbon dioxide and more.
Early detection of disease can have a dramatic impact on treatment success rates, and often means the difference between life and death. Treating common diseases like lung, breast, prostate and skin cancers in their early stages results in less complexity and increased affordability - improving the quality of life for those affected. Blood-aware technology may detect substances suggestive of disease, including complete blood count, blood protein testing, circulating tumor cells and more.
Without frequent monitoring, diseases like diabetes can wreak havoc on our bodies. Where routine pricks and pokes were once the only way to keep an eye on crucial levels, blood-aware technology makes it easy to non-invasively and continuously monitor levels without the discomfort, excess supplies and limitations of current standard practices. Detectable substances pertaining to chronic illness include oxygen, blood pH, blood glucose, sodium and more.
Want to learn more and get trial access to bloods.ai
software models?
Portuguese 
English
Spanish